At Morgan Compounding Pharmacy , we support you every step of the way on your journey to better health
Sources FDA Wegovy (semaglutide) prescribing information, 2025 Novo Nordisk Wegovy HD (semaglutide 7.2 mg) FDA approval announcement, March 2026 New England Journal of Medicine STEP 1 trial: once-weekly semaglutide in adults with overweight or obesity Nature Medicine STEP 5 trial: two-year effects of semaglutide in adults with overweight or obesity NCBI StatPearls Semaglutide pharmacology and clinical use Novo Nordisk Wegovy oral tablet (semaglutide 25 mg) FDA approval, December 2025 Drugs.com Semaglutide dosage guide Medical disclaimer This article is for informational purposes only and does not replace medical advice
Rotating injection sites (abdomen, thighs, upper arms) helps prevent this
In prospective data, 87% tolerated the switch without significant GI symptoms
Your cell phone and charger
Pharma company Novo Nordisk , maker of the weekly injectable drug Ozempic (semaglutide), touts its weight loss benefit in its advertising